The estimated Net Worth of Pincus X, L.P.Wp X Finance,... is at least $188 Million dollars as of 7 December 2020. Pincus Finance owns over 3,686,225 units of Outset Medical stock worth over $2,611,862 and over the last 4 years Pincus sold OM stock worth over $185,601,429.
Pincus has made over 1 trades of the Outset Medical stock since 2020, according to the Form 4 filled with the SEC. Most recently Pincus sold 3,686,225 units of OM stock worth $185,601,429 on 7 December 2020.
The largest trade Pincus's ever made was selling 3,686,225 units of Outset Medical stock on 7 December 2020 worth over $185,601,429. On average, Pincus trades about 3,686,225 units every 0 days since 2020. As of 7 December 2020 Pincus still owns at least 5,121,298 units of Outset Medical stock.
You can see the complete history of Pincus Finance stock trades at the bottom of the page.
Over the last 4 years, insiders at Outset Medical have traded over $829,589,795 worth of Outset Medical stock and bought 42,000 units worth $1,172,030 . The most active insiders traders include Pincus Llc Warburg, Pincus X, L.P.Warburg Pincu..., and Pincus X, L.P.Wp X Finance,.... On average, Outset Medical executives and independent directors trade stock every 7 days with the average trade being worth of $44,055. The most recent stock trade was executed by Leslie Trigg on 15 August 2024, trading 5,308 units of OM stock currently worth $4,459.
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Outset Medical executives and other stock owners filed with the SEC include: